Front Row Advisors LLC Illumina, Inc. Transaction History

Front Row Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$128.91 - $192.44 $515 - $769	-4 Reduced 5.88%	64 $8,000
Q1 2023 May 22, 2023	BUY	$193.75 - $232.55 $10,075 - $12,092	52 Added 325.0%	68 $16,000
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $10,075 - $12,092	-52 Reduced 76.47%	16 $7,000
Q4 2022 Feb 15, 2023	BUY	$187.24 - $242.74 $6,553 - $8,495	35 Added 106.06%	68 $14,000
Q3 2022 Nov 15, 2022	SELL	$177.23 - $227.44 $354 - $454	-2 Reduced 5.71%	33 $6,000
Q3 2021 Nov 03, 2021	SELL	$405.61 - $524.84 $405 - $524	-1 Reduced 2.78%	35 $14,000
Q1 2021 Apr 28, 2021	BUY	$361.28 - $504.76 $1,445 - $2,019	4 Added 12.5%	36 $14,000
Q3 2020 Nov 30, 2020	BUY	$268.51 - $400.74 $8,592 - $12,823	32 New	32 $10,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.